The Lundquist Center for Entrepreneurship kicks off its new Distinguished Lecture Series with Dr. Roger Newton, President and CEO of Esperion Therapeutics and co-discoverer of Lipitor, the most prescribed cholesterol-lowering medication in the world.
Dr. Newton discusses his ongoing efforts to commercialize cardiovascular treatments and his approach to securing capital and talent under difficult environmental conditions. His story and experiences provide interesting insights into the highs and lows of taking a scientific discovery from lab to market.
(5.00 out of 5) (5.00 out of 5) (5.00 out of 5) (5.00 out of 5) (5.00 out of 5)
Loading ...
